DNA. Bits is a cutting-edge brand that utilizes advanced technology to address the challenges of Big Data, HIPAA, and de-identified continuous sharing of genetic and correlated clinical data. With the aim of revolutionizing medicine, preventive care, and pharmacological breakthroughs, DNA.

Bits focuses on understanding the interactions between genes, health, diseases, lifestyle, and treatments on an individual basis. Using the power of blockchain cryptography, DNA. Bits enables secure and authenticated tagging, tracking, and cross-referencing of health-related data.

Their solutions allow access to large sets of genetic data and correlated clinical records while maintaining anonymity and privacy. They facilitate the aggregation of data from different sources without the need for a central database. DNA.

Bits also ensures double-blind authentication, verification, and audit for clinical trials, eliminating the need for a centralized data source or identification. By incentivizing consent and enabling granular and ongoing permissions, DNA. Bits empowers key holders to control the flow of data records.

Through their innovative approach, DNA. Bits is paving the way for the future of genetics and medical big data